"Prenosis AI Tool Receives FDA Approval for Sepsis Detection"

The FDA has authorized the first AI-driven diagnostic tool for sepsis, developed by Chicago-based company Prenosis, to predict the risk of the condition, which contributes to at least 350,000 deaths annually in the US. The tool, based on an algorithm trained with over 100,000 blood samples and clinical data, categorizes a patient's sepsis risk into four levels. This development comes as federal health agencies prioritize sepsis management, with hospitals increasingly considering the integration of artificial intelligence into patient care despite concerns among some frontline workers.